SBFM Sunshine Biopharma posts wider than expected Q4 2025 loss as shares close unchanged for the trading day Adidas Equity Performance and Running Category Strategy Analysis London Marathon Catalyst BKD Brookdale stock gains 176 percent following Q4 2025 results largely in line with analyst expectations Is Cango CANG stock showing downside risk Q4 2025 EPS Misses Views HCHL Happy City reports strong commercial segment momentum that offsets muted residential sales in the quarter